mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for SYTL4
Gene summary
Basic gene Info.Gene symbolSYTL4
Gene namesynaptotagmin-like 4
SynonymsSLP4
CytomapUCSC genome browser: Xq21.33
Type of geneprotein-coding
RefGenesNM_001129896.2,
NM_001174068.1,NM_080737.2,
Descriptionexophilin-2granuphilin-asynaptotagmin-like protein 4
Modification date20141207
dbXrefs MIM : 300723
HGNC : HGNC
Ensembl : ENSG00000102362
HPRD : 06735
Vega : OTTHUMG00000022004
ProteinUniProt: Q96C24
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_SYTL4
BioGPS: 94121
PathwayNCI Pathway Interaction Database: SYTL4
KEGG: SYTL4
REACTOME: SYTL4
Pathway Commons: SYTL4
ContextiHOP: SYTL4
ligand binding site mutation search in PubMed: SYTL4
UCL Cancer Institute: SYTL4
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for SYTL4
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C63R61WGBM1
C91I93TLUAD1
C66Q67RLUSC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for SYTL4
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C66Q67R0.22850814
C63R61W-1.0707874
C91I93T-0.84500311
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for SYTL4 from PDB

Top
Differential gene expression and gene-gene network for SYTL4
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of SYTL4 and the right PPI network was created from samples without mutations in the LBS of SYTL4. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for SYTL4
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for SYTL4

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|investigationalDB00030Insulin HumanBiotech
ApprovedDB00071Insulin PorkBiotech

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of SYTL4 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of SYTL4
Multiple alignments for Q96C24 in multiple species
LBSAA sequence# speciesSpecies
C63YSDRTCARCQE3Homo sapiens, Mus musculus, Rattus norvegicus
C66RTCARCQEGLG2Mus musculus, Rattus norvegicus
C66RTCARCQESLG1Homo sapiens
C88CNHLVCRECRV2Mus musculus, Rattus norvegicus
C88CNHLVCRDCRI1Homo sapiens
C91LVCRECRVLES2Mus musculus, Rattus norvegicus
C91LVCRDCRIQES1Homo sapiens


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas